Ernexa Therapeutics (ERNA) Non-Current Deffered Revenue (2010 - 2024)
Ernexa Therapeutics' Non-Current Deffered Revenue was $298,000 in Q2 2024, up 19.2% from $250,000 a year earlier but down 13.6% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Non-Current Deffered Revenue (2010 - 2024) Analysis & Trends
At the end of FY2023, Non-Current Deffered Revenue at Ernexa Therapeutics came in at $392,000.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 67.2% (FY2018 to FY2023).
- In earlier years, Non-Current Deffered Revenue was $2,000 in FY2020 (unchanged) and $2,000 in FY2019 (-93.3%).
- Quarterly Non-Current Deffered Revenue has moved between $1,000 (Q1 2020) and $392,000 (Q4 2023) over five years.
- Per Business Quant data, ERNA's Non-Current Deffered Revenue in the three quarters before Q2 2024 was $345,000 (Q1 2024), $392,000 (Q4 2023) and $250,000 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Ernexa Therapeutics | 2.43 Mn | -16.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 298,000.00 |
| Mar 31, 2024 | 345,000.00 |
| Dec 31, 2023 | 392,000.00 |
| Sep 30, 2023 | 250,000.00 |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 23,000.00 |
| Dec 31, 2018 | 30,000.00 |
| Jun 30, 2018 | 44,000.00 |
| Mar 31, 2018 | 50,000.00 |
| Dec 31, 2017 | 63,000.00 |
| Sep 30, 2017 | 85,000.00 |
| Jun 30, 2017 | 111,000.00 |
| Mar 31, 2017 | 179,000.00 |
| Dec 31, 2016 | 219,000.00 |
API Access
Ernexa Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();